DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+28.25%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.06B
AUM Growth
+$5.06B
(+23%)
Cap. Flow
+$868M
Cap. Flow
% of AUM
17.15%
Top 10 Holdings %
Top 10 Hldgs %
34.58%
Holding
151
New
52
Increased
21
Reduced
21
Closed
24
Top Buys
| 1 |
Biogen
BIIB
|
$110M |
| 2 |
ONCR
Oncorus, Inc.
ONCR
|
$92.1M |
| 3 |
The Oncology Institute
TOI
|
$59M |
| 4 |
CMAX
CareMax, Inc. Class A Common Stock
CMAX
|
$53.3M |
| 5 |
Cytokinetics
CYTK
|
$51.1M |
Top Sells
Sector Composition
| 1 | Healthcare | 69.84% |
| 2 | Industrials | 0.55% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Viatris
VTRS
$12.3B
| $295M | 5.82% | 15,724,000 +2,450,000 | +18% | +$45.9M |
|
2
CalciMedica
CALC
$37.7M
| $153M | 3.03% | 5,281,713 | – | – |
|
3
Centene
CNC
$14.3B
| $146M | 2.88% | 2,430,000 +602,000 | +33% | +$36.1M |
|
|
AFIB
4
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $125M | 2.47% | 4,341,799 | – | – |
|
5
Larimar Therapeutics
LRMR
$310M
| $110M | 2.18% | 5,144,539 | – | – |
|
|
6
Biogen
BIIB
$19.4B
| $110M | 2.17% | +448,000 | New | +$110M |
|
|
SWTX
7
DELISTED
SpringWorks Therapeutics
SWTX
| $105M | 2.07% | 1,442,970 +208,708 | +17% | +$15.1M |
|
|
ONCR
8
DELISTED
Oncorus, Inc.
ONCR
| $92.1M | 1.82% | +2,848,977 | New | +$92.1M |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – | -579,248 | Closed | -$66.3M |
|
10
Nkarta
NKTX
$151M
| $87.3M | 1.73% | 1,419,872 -998,900 | -41% | -$61.4M |
|
11
Rhythm Pharmaceuticals
RYTM
$6.85B
| $80.9M | 1.6% | 2,721,203 +824,156 | +43% | +$24.5M |
|
12
AdaptHealth
AHCO
$1.28B
| $67.8M | 1.34% | 1,806,332 +95,658 | +6% | +$3.59M |
|
13
Pacira BioSciences
PCRX
$1.2B
| $62.8M | 1.24% | 1,049,647 -148,178 | -12% | -$8.87M |
|
14
Mirum Pharmaceuticals
MIRM
$3.71B
| $60.2M | 1.19% | 3,448,912 | – | – |
|
|
15
The Oncology Institute
TOI
$318M
| $59M | 1.17% | +5,460,000 | New | +$59M |
|
|
OSH
16
DELISTED
Oak Street Health, Inc.
OSH
| $58.2M | 1.15% | 951,063 | – | – |
|
|
DFPHU
17
DELISTED
DFP Healthcare Acquisitions Corp. Unit
DFPHU
| $56.1M | 1.11% | 5,000,000 -5,460,000 | -52% | -$61.2M |
|
18
Revolution Medicines
RVMD
$7.1B
| $55.3M | 1.09% | 1,396,383 -400,000 | -22% | -$15.8M |
|
|
XLRN
19
DELISTED
Acceleron Pharma Inc.
XLRN
| $53.9M | 1.07% | 421,619 | – | – |
|
|
CMAX
20
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $53.3M | 1.05% | +3,418,750 | New | +$53.3M |
|
21
Fate Therapeutics
FATE
$120M
| – | – | -668,067 | Closed | -$26.7M |
|
|
22
Cytokinetics
CYTK
$4.23B
| $51.1M | 1.01% | +2,461,000 | New | +$51.1M |
|
|
DFHTU
23
DELISTED
Deerfield Healthcare Technology Acquisitions Corp. Unit
DFHTU
| $50.4M | 1% | 3,360,000 | – | – |
|
24
Brookdale Senior Living
BKD
$1.83B
| $48.8M | 0.97% | 11,023,465 -6,696,535 | -38% | -$29.7M |
|
|
BPMC
25
DELISTED
Blueprint Medicines
BPMC
| – | – | -405,386 | Closed | -$37.6M |
|